Audiological Management of Congenital CMV Infection: Current Trends and Future Perspectives
09-10, 09:00–10:00 (Europe/Istanbul), Audiology 2

<p>Congenital cytomegalovirus (cCMV) is the primary cause of non-genetic infantile sensorineural hearing loss (SNHL). The global prevalence is 0.64%, with a 17-20% risk of persistent sequelae in affected children. Patients with cCMV require sophisticated and multidisciplinary management, which includes clinical, laboratory, and instrumental examinations from infancy to school age. In recent years, significant progress has been made in preventing infection-related complications, including the effectiveness of antiviral treatments given during pregnancy to stop vertical transmission, the relationship between the stage of pregnancy and symptom severity, and advanced research into a cytomegalovirus vaccine. These developments have led to updates and adaptations of existing guidelines to better suit new circumstances and management needs. This aims to facilitate early infection diagnosis, implement therapeutic and rehabilitative strategies, and ensure proper monitoring of children’s development during their early years. Management of hearing loss caused by cCMV primarily emphasizes early detection and timely intervention. Newborn hearing screening programs, such as those using transient evoked otoacoustic emissions (TEAOE), alongside targeted cCMV testing in high-risk groups, play a crucial role in identifying children at risk. For infants diagnosed with hearing loss, early treatments—including hearing aids, cochlear implants, and speech therapy—can enhance outcomes and promote the development of language and communication skills.</p> <p>The author aims to highlight the challenges and recommendations regarding this topic in Italy, with a focus on early rehabilitation and audiological follow-up.</p>
<p>To discuss different topics concerning the congenital CMV infection and its effects on auditory and vestibular function, and provide recommendations related to this subject in Italy, emphasizing early rehabilitation and audiological follow-up.</p>
Moderator-Speaker Moderator-Speaker
Ayça Çiprut
Speaker Speaker
Francesca Yoshie Russo
Çağıl Gökdoğan
Belde ÇULHAOĞLU
Ayça Çiprut
<p>Ayca Ciprut (PhD) is a professor of audiology at Marmara University Medical School, Department of Audiology. Currently, she is the head of Audiology Department in Marmara University. She received MSc and PhD degrees in audiology from Marmara University, Istanbul. Her clinical focus is on pediatric audiology and cochlear implants. Her research interests include cochlear implants, auditory neuropathy spectrum disorder and cortical auditory evoked potentials.</p>
This speaker also appears in:
Francesca Yoshie Russo
<p>Francesca Yoshie Russo, MD, PhD is an Associate Professor of Otolaryngology at Sapienza University of Rome. She previously completed a surgical fellowship in Otolaryngology and Otology at Pitié Salpetrière Hospital in Paris. She earned her PhD in Neuroscience from Sapienza University of Rome, with prior research conducted at the Center for Hearing and Deafness at SUNY Buffalo. Her current clinical focus includes adult and pediatric audiology, as well as otologic surgery, while her research interests encompass adult and pediatric audiology, cochlear implants, and otology.</p>
This speaker also appears in:
Çağıl Gökdoğan
<p></p>
This speaker also appears in:
Belde ÇULHAOĞLU
<p></p>